The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrascom Inv Regulatory News (OIH)

  • This share is currently suspended. It was suspended at a price of 0.014

Share Price Information for Orascom Inv (OIH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.014
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.014
OIH Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OIH EGM Invitation

23 Sep 2020 09:10

RNS Number : 8591Z
Orascom Investment Holding S.A.E
23 September 2020
 

Invitation to attend

The Extraordinary General Assembly of Orascom Investment Holding

To be held on Monday, October 19th 2020 - 4 pm

 

In light of the current pandemic COVID-19 situation, the specific guidelines for conduct safety and precautions that have been rolled out by the State and the commitment and consideration of Orascom Investment Holding Company (S.A.E.) towards its shareholders, and the precautionary measures with respect to the suspension of any activities comprising large gatherings in order to contain the spread of the global pandemic COVID-19. Moreover, in light of the Prime Minister's Decree No. 606 for 2020, the Financial Regulatory Authority's statement and the General Authority for Investment decree no. 160 for 2020 in connection with convening General Assembly meetings via modern means of telecommunication.

 

Pursuant to Orascom Investment Holding S.A.E. Board of Directors resolution, the Chairman cordially invites the Company's shareholders, the members of its Board of Directors, the Financial Regulatory Authority, the General Authority for Investment and Free Zones, the Financial Regulatory Authority, and the auditor of the Company to attend the Extraordinary General Assembly Meeting of Orascom Investment Holding (S.A.E.) to convene on Monday October 19th, 2020 at 4 p.m. by means of modern audio-communication systems (video conference) using Zoom application via the following link (https://zoom.us/j/94578000350).

 

To discuss the following agenda:

 

1. To approve the demerger of the company horizontally into Orascom Investment Holding SAE ("Demerging Company") and a new company under the name Orascom Financial Holding ("Demerged Company");

2. To Approve the ratification of the demerger rationale;

 

3. To approve the valuation report issued by the Economic Performance Sector of the General Authority for Investment and Free Zones regarding the net equity of the Demerging and Demerged Companies;

4. To approve the apportionment and distribution of the assets, liabilities and equity between the Demerging Company and the Demerged Company in accordance with the terms and conditions of the detailed demerger plan and the auditor's report thereon in light of the valuation report issued by the Economic Performance Sector of the General Authority for Investment and Free Zones regarding the net Equity of the Demerging and Demerged Companies;

5. To approve the demerger contract based on the book value of Orascom Investment Holding in accordance with its financial statements for the financial year ending on 31/12/2019, and to amend Articles 6 and 7 of the Articles of Association, to reflect the reduction of the Authorized Capital and the Issued Capital and the Bylaws and the Articles of Association of the Demerged Company;

6. To approve continuing the listing of the Demerging Company's shares after the reduction of its Issued Capital and listing the shares of the Demerged Company on the Egyptian Stock Exchange once the demerger occurs and delegating the Chairman to submit a request to reduce the capital of the Demerging Company and to submit a request to list the Demerged Company on the Egyptian Stock Exchange.

7. To approve undertaking any necessary amendments on the global depository receipts program of the Demerging Company, and establishing a global depository receipts program for the Demerged Company upon incorporation, and delegating the Chairman to undertake all the procedures with all Governmental and non-governmental authorities.

8. To approve the restructuring of all affiliates and subsidiaries of the Demerging Company and the Demerged Company and authorizing the Chairman to finalize the procedures necessary for the transfer of ownership from the Demerging Company to the Demerged Company and authorize the chairman to sign purchase and sale orders and contracts, and to obtain the authority's approval for the exemption from mandatory tender offer and exemption from cash payments.

9. To approve (i) the pro forma financial statements of the Demerging Company and the Demerged Company for the financial years ending 31/12/2018 and 31/12/2019; (ii) the auditor's report on the pro forma financial statements; (iii) the Company's legal counsel memo re the compliance of the Company with the Demerger procedures and the applicable laws; (iv) ratify the Articles of Association and Statutes of the Demerged Company, and (v) approve amending Articles (6) and (7) of the Articles of Association of Demerging Company.

10. To authorize the Chairman of the Board of Directors to incorporate any amendments requested by the competent Authorities to the Articles of Association of the Demerging Company, the Articles of Association and Statutes of the Demerged Company and to ratify, the draft demerger program/plan and demerger contract. Moreover, to authorize the Chairman of the Board of Directors to take any decisions or procedures to complete the demerger process and ratify the Disclosure Report of each of the companies resulting from the demerger in accordance with Article 138 of the Executive Regulations of Law 159 of 1981.

 

We would like to draw the shareholders attention to the following:

 

First: Shareholders wishing to attend the Extraordinary General Assembly, should send the following documents to the e-mail (shareholders@OrascomIH.com) at least three days prior to the date of the Extraordinary General Assembly:

 

- A certified account statement issued by a custodian bank, freezing the balance of the shares reflected in the account statement for the purpose of attending the Extraordinary General Assembly;

- National ID or passport to prove the identity of the shareholder;

- Any additional documents in case of proxies or Power of Attorney;

- The voting card for the Extraordinary General Assembly's resolutions, available on the following link (https://orascomih.com/en/press-release/).

 

Second: The Company shall provide the shareholders with the Zoom meeting code upon the receipt, review and verification of all the aforementioned documents. The Zoom meeting code will enable the shareholder to participate in the meeting.

 

Third: A shareholder has the right to attend the meeting in person or by proxy by delegating another shareholder other than the members of the Board of Directors by virtue of power of attorney.

 

Fourth: A shareholder may not represent by proxy in the Extraordinary General Assembly a number of votes exceeding ten percent (10%) of the nominal shares of the Company's share capital or twenty percent (20%) of the shares present at the Meeting.

 

Fifth: The Extraordinary General Assembly shall not be validly held unless attended by a number of shareholders representing half of the nominal shares of the Company's share capital. In the event the quorum is not met, the Extraordinary General Assembly will reconvene within thirty days from the date of the first meeting (to be announced at the time). The second Extraordinary General Assembly shall not be valid unless attended by number of shareholders representing quarter of the nominal shares of the Company's share capital.

 

Chairman

Eng. Naguib Sawiris

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPURUBUPUURW
Date   Source Headline
15th Oct 20123:45 pmRNSSecond Price Monitoring Extn
15th Oct 20123:40 pmRNSPrice Monitoring Extension
15th Oct 20127:00 amRNSOTMT Assign to FT its GSA with ECMS
11th Oct 20123:45 pmRNSSecond Price Monitoring Extn
11th Oct 20123:40 pmRNSPrice Monitoring Extension
20th Aug 20126:11 pmRNSAcquisition effective date & listing cancellation
17th Aug 20126:01 pmRNSUpdate re recommended cash acquisition
10th Aug 20123:45 pmRNSSecond Price Monitoring Extn
10th Aug 20123:40 pmRNSPrice Monitoring Extension
27th Jul 20127:00 amRNSUpdate re recommended cash acquisition
16th Jul 20123:45 pmRNSSecond Price Monitoring Extn
16th Jul 20123:40 pmRNSPrice Monitoring Extension
6th Jul 201212:49 pmRNSResponse to announcement by Mr John Robinson
3rd Jul 20124:43 pmRNSDividend Declaration
29th Jun 20127:00 amRNSRelease of audited IFRS results for FY 2011
28th Jun 20125:49 pmRNSOGM Press Release 28-6-2012
26th Jun 20129:51 amRNSADMISSION TO TRADING ON THE LONDON STOCK EXCHANGE
25th Jun 20125:06 pmRNSOTMT expected admission Date
25th Jun 20127:00 amRNSFurther re Recommended Cash Acquisition
20th Jun 20125:39 pmRNSPublication of Prospectus
12th Jun 20129:36 amRNSStepping Down of CEO
7th Jun 20122:50 pmRNSResult of Special General Meeting
6th Jun 20123:45 pmRNSSecond Price Monitoring Extn
6th Jun 20123:40 pmRNSPrice Monitoring Extension
1st Jun 20123:40 pmRNSPrice Monitoring Extension
31st May 20123:45 pmRNSSecond Price Monitoring Extn
31st May 20123:40 pmRNSPrice Monitoring Extension
25th May 20126:09 pmRNSHolding(s) in Company
16th May 20127:00 amRNSInterim Management Statement
14th May 20125:36 pmRNSPosting of Circular
10th May 20122:32 pmRNSResult of AGM
3rd May 201212:51 pmRNSAnnual Information Update
2nd May 20129:40 amRNSForm 8.3 - Omega Insurance Holdings Limited
30th Apr 20129:33 amRNSForm 8.3 - Omega Insurance Holdings Ltd
27th Apr 20122:17 pmRNSHolding(s) in Company
27th Apr 201210:17 amRNSForm 8.3 - OMEGA INSURANCE HOLD LTD
25th Apr 20126:22 pmRNSOffer for Omega Insurance Holdings Limited
13th Apr 201211:52 amRNSHolding(s) in Company
12th Apr 20128:03 amRNSFT and OTMT Joint Announcement
11th Apr 20126:05 pmRNSAnnual Financial Report
30th Mar 20124:41 pmRNSSecond Price Monitoring Extn
30th Mar 20124:35 pmRNSPrice Monitoring Extension
29th Mar 20126:10 pmRNSHolding(s) in Company
29th Mar 20125:55 pmRNSDirector/PDMR Shareholding
27th Mar 20124:11 pmRNSStatement re. Press Comment
14th Mar 20127:00 amRNSHolding(s) in Company
6th Mar 20127:00 amRNSFinal Results
24th Jan 201210:59 amRNSNotice of Results
20th Jan 20124:05 pmRNSResponse to Barbican statement
20th Jan 20127:00 amRNSStatement re Omega Insurance Holdings Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.